Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Zhukovsky, Mikhail A ^a,b,d   Basmaciogullari, Stéphane ^a,e   Pacheco, Beatriz ^a   Wang, Liping ^a   Madani, Navid ^a   Haim, Hillel ^a   Sodroski, Joseph ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d SAARLAND UNIVERSITY   (Germany)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; CHEMOKINE RECEPTOR CXCR4; CD4 ANTIGEN; CXCR4 PROTEIN, HUMAN; PROTEOLIPID; PROTEOLIPOSOMES; VIRUS RECEPTOR;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DENATURATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGAND BINDING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOLIPOSOME; TEMPERATURE SENSITIVITY; THERMOSTABILITY; HEAT; METABOLISM; PROTEIN BINDING; PROTEIN DENATURATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD4; HIV-1; HOT TEMPERATURE; PROTEIN BINDING; PROTEIN DENATURATION; PROTEOLIPIDS; RECEPTORS, CXCR4; RECEPTORS, VIRUS;

EID: 78149461804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013249     Document Type: Article

References (126)

1. Wyatt R, Sodroski J (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280: 1884-1888.
2. Weber J, Piontkivska H, Quinones-Mateu ME (2006) HIV type 1 tropism and inhibitors of viral entry: clinical implications. AIDS Rev 8: 60-77.
3. Alkhatib G, Berger EA (2007) HIV coreceptors: from discovery and designation to new paradigms and promise. Eur J Med Res 12: 375-384.
4. Huang Z, Li S, Korngold R (1997) Immunoglobulin superfamily proteins: structure, mechanisms, and drug discovery. Biopolymers 43: 367-382.
5. Miceli MC, Parnes JR (1993) Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol 53: 59-122.
6. Bourgeois R, Mercier J, Paquette-Brooks I, Cohen EA (2006) Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry. Retrovirology 3: 31.
7. Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, Schlossman SF (1988) The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc Natl Acad Sci U S A 85: 5190-5194.
8. Veillette A, Bookman MA, Horak EM, Bolen JB (1988) The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55: 301-308.
9. Straus DB, Weiss A (1992) Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593.
10. Sattentau QJ, Clapham PR, Weiss RA, Beverley PC, Montagnier L, et al. (1988) The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. Aids 2: 101-105.
11. Murdoch C (2000) CXCR4: chemokine receptor extraordinaire. Immunol Rev 177: 175-184.
12. Liang X (2008) CXCR4, inhibitors and mechanisms of action. Chem Biol Drug Des 72: 97-110.
13. Alkhatib G (2009) The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 4: 96-103.
14. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, et al. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829-833.
15. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, et al. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833-835.
16. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242.
17. Mines M, Ding Y, Fan GH (2007) The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr Med Chem 14: 2456-2470.
18. Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179.
19. Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94.
20. Fulton AM (2009) The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 11: 125-131.
21. Busillo JM, Benovic JL (2007) Regulation of CXCR4 signaling. Biochim Biophys Acta 1768: 952-963.
22. Kawai T, Malech HL (2009) WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol 16: 20-26.
23. Tamamura H, Fujii N (2005) The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis. Expert Opin Ther Targets 9: 1267-1282.
24. Hogaboam CM, Carpenter KJ, Schuh JM, Proudfoot AA, Bridger G, et al. (2005) The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease. Pharmacol Ther 107: 314-328.
25. Doms RW (2000) Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology 276: 229-237.
26. Cudd A, Noonan CA, Tosi PF, Melnick JL, Nicolau C (1990) Specific interaction of CD4-bearing liposomes with HIV-infected cells. J Acquir Immune Defic Syndr 3: 109-114.
27. Flasher D, Konopka K, Chamow SM, Dazin P, Ashkenazi A, et al. (1994) Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). Biochim Biophys Acta 1194: 185-196.
28. Puri A, Dimitrov DS, Golding H, Blumenthal R (1992) Interactions of CD4+ plasma membrane vesicles with HIV-1 and HIV-1 envelope glycoproteinexpressing cells. J Acquir Immune Defic Syndr 5: 915-920.
29. Simm M, Pekarskaya O, Volsky DJ (1996) Synthesis of full-length viral DNA in CD4-positive membrane vesicles exposed to HIV-1. A model for studies of early stages of the hiv-1 life cycle. J Biol Chem 271: 28266-28270.
30. Van Broekhoven CL, Altin JG (2001) A novel system for convenient detection of low-affinity receptor-ligand interactions: chelator-lipid liposomes engrafted with recombinant CD4 bind to cells expressing MHC class II. Immunol Cell Biol 79: 274-284.
31. Devesa F, Chams V, Dinadayala P, Stella A, Ragas A, et al. (2002) Functional reconstitution of the HIV receptors CCR5 and CD4 in liposomes. Eur J Biochem 269: 5163-5174.
32. Mirzabekov T, Kontos H, Farzan M, Marasco W, Sodroski J (2000) Paramagnetic proteoliposomes containing a pure, native, and oriented seventransmembrane segment protein, CCR5. Nat Biotechnol 18: 649-654.
33. Babcock GJ, Mirzabekov T, Wojtowicz W, Sodroski J (2001) Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes. J Biol Chem 276: 38433-38440.
34. Oprian DD, Molday RS, Kaufman RJ, Khorana HG (1987) Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. Proc Natl Acad Sci U S A 84: 8874-8878.
35. Kasahara M, Hinkle PC (1977) Reconstitution and purification of the Dglucose transporter from human erythrocytes. J Biol Chem 252: 7384-7390.
36. Rigaud JL (2002) Membrane proteins: functional and structural studies using reconstituted proteoliposomes and 2-D crystals. Braz J Med Biol Res 35: 753-766.
37. Jeremic A, Kelly M, Cho JA, Cho SJ, Horber JK, et al. (2004) Calcium drives fusion of SNARE-apposed bilayers. Cell Biol Int 28: 19-31.
38. Mayer LD, Hope MJ, Cullis PR (1986) Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 858: 161-168.
39. Castile JD, Taylor KM (1999) Factors affecting the size distribution of liposomes produced by freeze-thaw extrusion. Int J Pharm 188: 87-95.
40. Traikia M, Warschawski DE, Recouvreur M, Cartaud J, Devaux PF (2000) Formation of unilamellar vesicles by repetitive freeze-thaw cycles: characterization by electron microscopy and 31P-nuclear magnetic resonance. Eur Biophys J 29: 184-195.
41. Menger FM, Gabrielson KD (1995) Cytomimetic organic chemistry: early developments. Angew Chem Int Ed Engl 34: 2091-2106.
42. Healey D, Dianda L, Moore JP, McDougal JS, Moore MJ, et al. (1990) Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med 172: 1233-1242.
43. Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, et al. (1989) Leucocyte typing IV: White cell differentiation antigens Oxford University Press; Oxford, New York, Tokyo.
44. Klasse PJ, Rosenkilde MM, Signoret N, Pelchen-Matthews A, Schwartz TW, et al. (1999) CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection. J Virol 73: 7453-7466.
45. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, et al. (1996) CD4- independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87: 745-756.
46. Baribaud F, Edwards TG, Sharron M, Brelot A, Heveker N, et al. (2001) Antigenically distinct conformations of CXCR4. J Virol 75: 8957-8967.
47. Carnec X, Quan L, Olson WC, Hazan U, Dragic T (2005) Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1. J Virol 79: 1930-1933.
48. Brelot A, Heveker N, Adema K, Hosie MJ, Willett B, et al. (1999) Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. J Virol 73: 2576-2586.
49. Wu L, LaRosa G, Kassam N, Gordon CJ, Heath H, et al. (1997) Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med 186: 1373-1381.
50. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, et al. (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 coreceptor. Nat Med 4: 72-77.
51. Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, et al. (2004) Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 37: 1253-1262.
52. Fricker SP, Anastassov V, Cox J, Darkes MC, Grujic O, et al. (2006) Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol 72: 588-596.
53. De Clercq E (2009) The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol 77: 1655-1664.
54. Seibert C, Sakmar TP (2004) Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs. Curr Pharm Des 10: 2041-2062.
55. Schols D, Struyf S, Van Damme J, Este JA, Henson G, et al. (1997) Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 186: 1383-1388.
56. Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, et al. (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A 96: 5698-5703.
57. Madani N, Hubicki AM, Perdigoto AL, Springer M, Sodroski J (2007) Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry. J Virol 81: 532-538.
58. Gozansky EK, Louis JM, Caffrey M, Clore GM (2005) Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha. J Mol Biol 345: 651-658.
59. Ryu EK, Kim TG, Kwon TH, Jung ID, Ryu D, et al. (2007) Crystal structure of recombinant human stromal cell-derived factor-1alpha. Proteins 67: 1193-1197.
60. Juarez J, Bendall L, Bradstock K (2004) Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis. Curr Pharm Des 10: 1245-1259.
61. Stromberg A, Ryttsen F, Chiu DT, Davidson M, Eriksson PS, et al. (2000) Manipulating the genetic identity and biochemical surface properties of individual cells with electric-field-induced fusion. Proc Natl Acad Sci U S A 97: 7-11.
62. Mastrobattista E, Koning GA, van Bloois L, Filipe AC, Jiskoot W, et al. (2002) Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J Biol Chem 277: 27135-27143.
63. Hoekstra D, de Boer T, Klappe K, Wilschut J (1984) Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23: 5675-5681.
64. Bailey A, Zhukovsky M, Gliozzi A, Chernomordik LV (2005) Liposome composition effects on lipid mixing between cells expressing influenza virus hemagglutinin and bound liposomes. Arch Biochem Biophys 439: 211-221.
65. Bee MS, Hulme EC (2007) Functional analysis of transmembrane domain 2 of the M1 muscarinic acetylcholine receptor. J Biol Chem 282: 32471-32479.
66. Claeysen S, Sebben M, Becamel C, Parmentier ML, Dumuis A, et al. (2001) Constitutively active mutants of 5-HT4 receptors: are they in unique active states? EMBO Rep 2: 61-67.
67. Kolena J, Scsuková S, Ježová M (2002) Thermal destabilization of ovarian LH/hCG receptors by negatively charged lipids. Exp Clin Endocrinol Diabetes 110: 77-79.
68. Stenlund P, Babcock GJ, Sodroski J, Myszka DG (2003) Capture and reconstitution of G protein-coupled receptors on a biosensor surface. Anal Biochem 316: 243-250.
69. Navratilova I, Sodroski J, Myszka DG (2005) Solubilization, stabilization and purification of chemokine receptors using biosensor technology. Anal Biochem 339: 271-281.
70. Steffens CM, Hope TJ (2004) Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J Virol 78: 9573-9578.
71. Nguyen DH, Giri B, Collins G, Taub DD (2005) Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304: 559-569.
72. Jacobs A, Garg H, Viard M, Raviv Y, Puri A, et al. (2008) HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development. Vaccine 26: 3026-3035.
73. Rawat SS, Zimmerman C, Johnson BT, Cho E, Lockett SJ, et al. (2008) Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion. Mol Membr Biol 25: 83-94.
74. Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, et al. (2002) Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci U S A 99: 9410-9414.
75. Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, et al. (2004) Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoproteintriggered membrane fusion. Virology 318: 55-65.
76. Rawat SS, Viard M, Gallo SA, Blumenthal R, Puri A (2006) Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion. Glycoconj J 23: 189-197.
77. Magerus-Chatinet A, Yu H, Garcia S, Ducloux E, Terris B, et al. (2007) Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells. Virology 362: 67-74.
78. Viard M, Parolini I, Rawat SS, Fecchi K, Sargiacomo M, et al. (2004) The role of glycosphingolipids in HIV signaling, entry and pathogenesis. Glycoconj J 20: 213-222.
79. Nehete PN, Vela EM, Hossain MM, Sarkar AK, Yahi N, et al. (2002) A post- CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. Antiviral Res 56: 233-251.
80. Hubbard R (1958) The thermal stability of rhodopsin and opsin. J Gen Physiol 42: 259-280.
81. Shnyrov VL, Berman AL, Lazarev UA, Etingof RN (1977) Thermal stability of squid rhodopsin in photoreceptor membrane and their triton extracts. Vision Res 17: 169-173.
82. Berman AL, Shnyrov VL, Rychkova MP, Semen'kov PG (1981) Thermostability of sea fish rhodopsins. Vision Res 21: 731-737.
83. Sudo Y, Yamabi M, Iwamoto M, Shimono K, Kamo N (2003) Interaction of Natronobacterium pharaonis phoborhodopsin (sensory rhodopsin II) with its cognate transducer probed by increase in the thermal stability. Photochem Photobiol 78: 511-516.
84. Aymard C, Belarbi A (2000) Kinetics of thermal deactivation of enzymes: a simple three parameter phenomenological model can describe the decay of enzyme activity, irrespectively of the mechanism. Enzyme Microb Technol 27: 612-618.
85. Ling AC, Lund DB (1978) Determining kinetic parameters for thermal inactivation of heat-resistant and heat-labile isozymes from thermal destruction curves. J Food Sci 43: 1307-1310.
86. Zale SE, Klibanov AM (1984) Mechanisms of irreversible thermoinactivation of enzymes. Ann N Y Acad Sci 434: 20-26.
87. Sadana A, Henley JP (1988) Influence of pH on enzyme stabilization: an analysis using series-type mechanism. J Biotechnol 7: 95-112.
88. Sadana A (1993) Models of enzyme deactivation. In: Gupta MN, ed. Thermostability of Enzymes. New Delhi: Narosa Publishing House. pp 84-93.
89. Babcock GJ, Farzan M, Sodroski J (2003) Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J Biol Chem 278: 3378-3385.
90. Brouillette CG, McMichens RB, Stern LJ, Khorana HG (1989) Structure and thermal stability of monomeric bacteriorhodopsin in mixed phospholipid/detergent micelles. Proteins 5: 38-46.
91. Neet KE, Timm DE (1994) Conformational stability of dimeric proteins: quantitative studies by equilibrium denaturation. Protein Sci 3: 2167-2174.
92. Lin CT, Kuo TJ, Shaw JF, Kao MC (1999) Characterization of the dimermonomer equilibrium of the papaya Copper/Zinc superoxide dismutase and its equilibrium shift by a single amino acid mutation. J Agric Food Chem 47: 2944-2949.
93. Levi V, Rossi JP, Castello PR, Gonzalez Flecha FL (2002) Structural significance of the plasma membrane calcium pump oligomerization. Biophys J 82: 437-446.
94. Pollegioni L, Iametti S, Fessas D, Caldinelli L, Piubelli L, et al. (2003) Contribution of the dimeric state to the thermal stability of the flavoprotein Damino acid oxidase. Protein Sci 12: 1018-1029.
95. Byun JS, Rhee JK, Kim ND, Yoon J, Kim DU, et al. (2007) Crystal structure of hyperthermophilic esterase EstE1 and the relationship between its dimerization and thermostability properties. BMC Struct Biol 7: 47.
96. Lukasheva EV, Zhukovskii AP, Soda K, Berezov TT (1991) Thermal-stability of L-lysine-alpha-oxidase from Trichoderma sp. Biochemistry-Moscow 56: 738-743.
97. Lassalle MW, Hinz HJ (1998) Unfolding of the tetrameric loop deletion mutant of ROP protein is a second-order reaction. Biochemistry 37: 8465-8472.
98. Parr GR, Hammes GG (1976) A kinetic study of the subunit dissociation and reassembly of rabbit muscle phosphofructokinase. Biochemistry 15: 857-862.
99. Renosto F, Seubert PA, Knudson P, Segel IH (1985) APS kinase from Penicillium chrysogenum. Dissociation and reassociation of subunits as the basis of the reversible heat inactivation. J Biol Chem 260: 1535-1544.
100. Benitez-Cardoza CG, Rojo-Dominguez A, Hernandez-Arana A (2001) Temperature-induced denaturation and renaturation of triosephosphate isomerase from Saccharomyces cerevisiae: evidence of dimerization coupled to refolding of the thermally unfolded protein. Biochemistry 40: 9049-9058.
101. Basmaciogullari S, Pacheco B, Bour S, Sodroski J (2006) Specific interactions of CXCR4 with CD4 and CD8a: Functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion. Virology 353: 52-67.
102. Li-Chan E, Kummer A, Losso JN, Kitts DD, Nakai S (1995) Stability of bovine immunoglobulins to thermal treatment and processing. Food Res Int 28: 9-16.
103. Mainer G, Sánchez L, Ena JM, Calvo M (1997) Kinetic and thermodynamic parameters for heat denaturation of bovine milk IgG, IgA and IgM. J Food Sci 62: 1034-1038.
104. Cioci F, Lavecchia R (1998) Sorbitol-mediated stabilization of human IgG against thermal inactivation. Biotechnol Tech 12: 855-858.
105. Chen C-C, Tu Y-Y, Chang H-M (2000) Thermal stability of bovine milk immunoglobulin G (IgG) and the effect of added thermal protectants on the stability. J Food Sci 65: 188-193.
106. Dominguez E, Perez MD, Puyol P, Sanchez L, Calvo M (2001) Effect of pH on antigen-binding activity of IgG from bovine colostrum upon heating. J Dairy Res 68: 511-518.
107. Saito K, Sarai A, Oda M, Azuma T, Kozono H (2003) Thermodynamic analysis of the increased stability of major histocompatibility complex class II molecule I-Ek complexed with an antigenic peptide at an acidic pH. J Biol Chem 278: 14732-14738.
108. Lucisano M, Pompei C, Casiraghi E, Rizzo AM (1994) Milk pasteurization: Evaluation of thermal damage. Ital J Food Sci 6: 185-197.
109. El-Loly MM, Awad AA, Mansour AIA (2007) Thermal kinetics denaturation of buffalo milk immunoglobulins. Int J Dairy Sci 2: 292-301.
110. Dannenberg F, Kessler H-G (1988) Reaction kinetics of the denaturation of whey proteins in milk. J Food Sci 53: 258-263.
111. Cao J, Wang X, Zheng H (2007) Comparative studies on thermoresistance of protein G-binding region and antigen determinant region of immunoglobulin G in acidic colostral whey. Food Agric Immunol 18: 17-30.
112. Standfuss J, Xie G, Edwards PC, Burghammer M, Oprian DD, et al. (2007) Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol 372: 1179-1188.
113. Magnani F, Shibata Y, Serrano-Vega MJ, Tate CG (2008) Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor. Proc Natl Acad Sci U S A 105: 10744-10749.
114. Serrano-Vega MJ, Magnani F, Shibata Y, Tate CG (2008) Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form. Proc Natl Acad Sci U S A 105: 877-882.
115. Shibata Y, White JF, Serrano-Vega MJ, Magnani F, Aloia AL, et al. (2009) Thermostabilization of the neurotensin receptor NTS1. J Mol Biol 390: 262-277.
116. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, et al. (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454: 486-491.
117. Warne T, Serrano-Vega MJ, Tate CG, Schertler GF (2009) Development and crystallization of a minimal thermostabilised G protein-coupled receptor. Protein Expr Purif 65: 204-213.
118. Haque ME, McIntosh TJ, Lentz BR (2001) Influence of lipid composition on physical properties and peg-mediated fusion of curved and uncurved model membrane vesicles: "nature's own" fusogenic lipid bilayer. Biochemistry 40: 4340-4348.
119. Zhukovsky MA, Markovic I, Bailey AL (2007) Influence of calcium on lipid mixing mediated by influenza hemagglutinin. Arch Biochem Biophys 465: 101-108.
120. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, et al. (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 70: 1100-1108.
121. Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, et al. (2005) Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci U S A 102: 13372-13377.
122. Karlsson GB, Halloran M, Li J, Park IW, Gomila R, et al. (1997) Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J Virol 71: 4218-4225.
123. Hill CG (1977) Basic concepts in chemical kinetics - determination of the reaction rate expression. In An Introduction to Chemical Engineering Kinetics and Reactor Design Wiley: New York. pp 24-75.
124. Ramaswamy HS, van de Voort FR, Ghazala S (1989) An analysis of TDT and Arrhenius methods for handling process and kinetic data. J Food Sci 54: 1322-1326.
125. Stoforos NG (1995) Thermal-process design. Food Control 6: 81-94.
126. De Vrij W, Heyne RI, Konings WN (1989) Characterization and application of a thermostable primary transport system: cytochrome-C oxidase from Bacillus stearothermophilus. Eur J Biochem 178: 763-770.